newsfilter
← Latest News
GlobeNewswire·

HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter

MIRAMAR, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ:HCWB), a U.S.-based clinical-stage biopharmaceutical company developing transformative